About Lamda
Lamda was established in 1996 in Koropi, Greece, as a laboratory specializing in the pharmaceutical sector. Operations center on the development of generic drugs, alongside the delivery of research services to support drug innovation and testing. The facility is managed by Angelos Karatzas as Managing Director, with activities conducted primarily in Europe under the domain lamdalabs.eu. Focus remains on regulatory-compliant processes for generic formulations and analytical services.
- Headquarter Koropi, Greece
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Adragos Pharma
(Mar 20, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Lamda
Detailed funding history for Lamda
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Lamda
Lamda has secured backing from 1 investor. Prominent investors backing the company include Adragos Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare sector investments are managed by a private equity fund.
|
Locked | Locked | Locked |
Investor details for Lamda
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lamda
Investment portfolio details for Lamda
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lamda
Detailed financials for Lamda
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lamda Comparisons
Peer comparison for Lamda
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lamda
Detailed competitors of Lamda
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lamda
Complete news archive for Lamda
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lamda
Lamda was founded in 1996.
Lamda is headquartered in Koropi, Greece.
Lamda was established in 1996 in Koropi, Greece, as a laboratory specializing in the pharmaceutical sector. Operations center on the development of generic drugs, alongside the delivery of research services to support drug innovation and testing. The facility is managed by Angelos Karatzas as Managing Director, with activities conducted primarily in Europe under the domain lamdalabs.eu. Focus remains on regulatory-compliant processes for generic formulations and analytical services.
Lamda has 1 investor. Key investors include Adragos Pharma.